These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 27511964

  • 21. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
    Twine S, Shen H, Harris G, Chen W, Sjostedt A, Ryden P, Conlan W.
    Vaccine; 2012 May 21; 30(24):3634-45. PubMed ID: 22484348
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Characterization of Schu S4 aro mutants as live attenuated tularemia vaccine candidates.
    Cunningham AL, Mann BJ, Qin A, Santiago AE, Grassel C, Lipsky M, Vogel SN, Barry EM.
    Virulence; 2020 Dec 21; 11(1):283-294. PubMed ID: 32241221
    [Abstract] [Full Text] [Related]

  • 25. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q, Bowen R, Lee BY, Dillon BJ, Masleša-Galić S, Horwitz MA.
    Vaccine; 2016 Sep 22; 34(41):4969-4978. PubMed ID: 27577555
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes.
    Pasetti MF, Cuberos L, Horn TL, Shearer JD, Matthews SJ, House RV, Sztein MB.
    Vaccine; 2008 Mar 25; 26(14):1773-85. PubMed ID: 18308432
    [Abstract] [Full Text] [Related]

  • 28. Vaccination of Fischer 344 rats against pulmonary infections by Francisella tularensis type A strains.
    Wu TH, Zsemlye JL, Statom GL, Hutt JA, Schrader RM, Scrymgeour AA, Lyons CR.
    Vaccine; 2009 Jul 23; 27(34):4684-93. PubMed ID: 19520198
    [Abstract] [Full Text] [Related]

  • 29. Protective effects of the Francisella tularensis ΔpdpC mutant against its virulent parental strain SCHU P9 in Cynomolgus macaques.
    Tian D, Uda A, Ami Y, Hotta A, Park ES, Nagata N, Iwata-Yoshikawa N, Yamada A, Hirayama K, Miura K, Koyama Y, Azaki M, Morikawa S.
    Sci Rep; 2019 Jun 24; 9(1):9193. PubMed ID: 31235714
    [Abstract] [Full Text] [Related]

  • 30. Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy.
    Shen H, Harris G, Chen W, Sjostedt A, Ryden P, Conlan W.
    PLoS One; 2010 Oct 12; 5(10):e13349. PubMed ID: 20967278
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background.
    Chen W, Shen H, Webb A, KuoLee R, Conlan JW.
    Vaccine; 2003 Sep 08; 21(25-26):3690-700. PubMed ID: 12922099
    [Abstract] [Full Text] [Related]

  • 35. Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination.
    Rockx-Brouwer D, Chong A, Wehrly TD, Child R, Crane DD, Celli J, Bosio CM.
    PLoS One; 2012 Sep 08; 7(5):e37752. PubMed ID: 22662210
    [Abstract] [Full Text] [Related]

  • 36. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).
    De Pascalis R, Chou AY, Ryden P, Kennett NJ, Sjöstedt A, Elkins KL.
    mBio; 2014 Apr 08; 5(2):e00936. PubMed ID: 24713322
    [Abstract] [Full Text] [Related]

  • 37. A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge.
    Pechous RD, McCarthy TR, Mohapatra NP, Soni S, Penoske RM, Salzman NH, Frank DW, Gunn JS, Zahrt TC.
    PLoS One; 2008 Jun 25; 3(6):e2487. PubMed ID: 18575611
    [Abstract] [Full Text] [Related]

  • 38. Preclinical testing of a vaccine candidate against tularemia.
    Suresh RV, Ma Z, Sunagar R, Bhatty V, Banik S, Catlett SV, Gosselin EJ, Malik M, Bakshi CS.
    PLoS One; 2015 Jun 25; 10(4):e0124326. PubMed ID: 25897786
    [Abstract] [Full Text] [Related]

  • 39. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.
    Wu TH, Hutt JA, Garrison KA, Berliba LS, Zhou Y, Lyons CR.
    Infect Immun; 2005 May 25; 73(5):2644-54. PubMed ID: 15845466
    [Abstract] [Full Text] [Related]

  • 40. Mucosal immunization with live attenuated Francisella novicida U112ΔiglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat model.
    Signarovitz AL, Ray HJ, Yu JJ, Guentzel MN, Chambers JP, Klose KE, Arulanandam BP.
    PLoS One; 2012 May 25; 7(10):e47639. PubMed ID: 23118885
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.